A Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Anti-Oestrogen Therapy Delayed Until After Radiotherapy.

Trial Profile

A Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Anti-Oestrogen Therapy Delayed Until After Radiotherapy.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms STARS
  • Most Recent Events

    • 24 Jan 2017 Status changed from recruiting to active, no longer recruiting.
    • 16 May 2013 Planned end date changed from 1 May 2015 to 1 Dec 2024 as reported by ClinicalTrials.gov.
    • 08 Jul 2011 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top